Erica has worked on numerous important merger and acquisitions, EV methodology reviews and enhancements, actuarial modelling (embedded values, Solvency II/ RBC, US GAAP) , business planning, pricing and capital management projects in most of the countries in the Asia-Pacific region, especially Hong Kong, Thailand, and Vietnam.

• Playing a leading role or acting as a core member/project manager on various M&A and IPO projects in the Asia-Pacific region. Tasks include:
  • Constructing actuarial models required in various appraisal valuations
  • Conducting comprehensive Prophet model reviews
  • Providing market benchmarking support, including new business margin / assumptions benchmarking, providing expense assumptions benchmarking, and assessing product trends
• Performing regular embedded value and value of new business reviews for insurance companies in Hong Kong and Thailand
• Providing support to companies in Thailand relating to enhancing embedded value methodologies and capital management
• Performing purchase GAAP reviews for insurance companies in Hong Kong, Indonesia, and Thailand
• Carrying out business planning for potential joint venture/ bancassurance agreement opportunities in several markets, including Hong Kong, Thailand, and Vietnam
• Assisting a multinational company to build an ALM model to conduct SAA studies and capital projections under various capital regimes
• Comparing the cost of capital across various capital regimes and internal economic capital requirements for Asia companies
• Performing appointed actuary tasks for various Hong Kong and Macau companies
• Performing ORSA reviews for a Hong Kong company
• Assisting as a secondment for numerous companies in various roles, including:
  • Working with a Belgium company’s IFRS 17 implementation team
  • Working with an ERM team of a large multinational company in The Netherlands on Solvency II ratio sensitivities analyses, preparing the risk section in the company's Annual Report, and assisting on EIOPA stress testing projects
  • Implementing and enhancing actuarial models for the purpose of Solvency II reporting, performing new product SOE analyses, model efficiency improvements, and model standardisations for companies